Yes, thank you very much, Madam Chair.
First of all, I do want to thank the MS Society for your partnership, but also for your support. As you mentioned, research in Canada on this issue is unprecedented in terms of how quickly it is moving forward. I do appreciate the positive working environment you have with the federal government. As you said earlier, all members of the House would like to see this move forward as quickly as possible. Thank you for supporting the research and for your support for proper ethical consultation before we move forward with any experimental treatments on Canadians.
My question is actually for Dr. Kleiner-Fisman. First, I want to say thank you very much for being here today, and say hello to Dr. Reichman. When he was in committee I thought he was one of the most forward-thinking witnesses we had.
I have an interest in technology and innovation, and I was wondering what role can assistive technological devices play in the treatment and rehabilitation of persons with movement disorders and Parkinson's?